Drugs / Blinded clopidogrel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01121224 | Jan 2012 → Dec 2016 | atherosclerosis | VA Office of Research and Development | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Blinded clopidogrel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01121224 ↗ |